Block listing Interim Review
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan |
|||
|
Period of return: |
From: |
1 November 2019 |
To: |
30 April 2020 |
|
Balance of unallotted securities under scheme(s) from previous return: |
153,724 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
370,000 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
388,348 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
135,376 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares |
|||
|
Period of return: |
From: |
1 November 2019 |
To: |
30 April 2020 |
|
Balance of unallotted securities under scheme(s) from previous return: |
835,095 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
581,004 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
254,091 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline 2009 Share Option Plan - ADS |
|||
|
Period of return: |
From: |
1 November 2019 |
To: |
30 April 2020 |
|
Balance of unallotted securities under scheme(s) from previous return: |
5,391,416 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
698,736 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
4,692,680 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
|
Name of applicant: |
GlaxoSmithKline plc |
|||
|
Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
|
Period of return: |
From: |
1 November 2019 |
To: |
30 April 2020 |
|
Balance of unallotted securities under scheme(s) from previous return: |
2,145,812 |
|||
|
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
|
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
698,407 |
|||
|
Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,447,405 |
|||
|
Name of contact: |
Victoria Whyte |
|
Telephone number of contact: |
020 8047 5000 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Latest directors dealings
- 3 hours ago Centrica
- 4 hours ago Northern Bear
- 4 hours ago Weir Group
- 4 hours ago Legal & General Group
- 4 hours ago Legal & General Group